share_log

PainReform | 6-K/A: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K/A: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K/A:外国发行人报告(业绩相关)
美股SEC公告 ·  2024/08/29 04:34

Moomoo AI 已提取核心信息

PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.
PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.
PainReform宣布将于2024年9月30日举行年度股东大会。主要提案包括重新选举奥古斯丁·劳勒和艾伦·S·巴伦博士为三年期的外部董事,以及批准向董事和高管授予期权。公司提议向董事长兼临时首席执行官伊胡德·盖勒博士授予146,318个期权,向其他董事各授予22,000个期权。这些期权的行权价格为每股0.54美元。股东还将投票重新任命Kesselman & Kesselman为2024年的独立审计师。会议将在公司位于以色列贝尔谢巴的律师事务所举行。2024年9月3日及之前的股东有资格投票。代理材料可在PainReform的网站上获取。
PainReform宣布将于2024年9月30日举行年度股东大会。主要提案包括重新选举奥古斯丁·劳勒和艾伦·S·巴伦博士为三年期的外部董事,以及批准向董事和高管授予期权。公司提议向董事长兼临时首席执行官伊胡德·盖勒博士授予146,318个期权,向其他董事各授予22,000个期权。这些期权的行权价格为每股0.54美元。股东还将投票重新任命Kesselman & Kesselman为2024年的独立审计师。会议将在公司位于以色列贝尔谢巴的律师事务所举行。2024年9月3日及之前的股东有资格投票。代理材料可在PainReform的网站上获取。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息